Background: Diabetes mellitus and hypertension frequently coexist, and adults with both conditions often require multiple medicines, increasing the risk of medication burden, poor adherence, and suboptimal disease control.
Objective: To synthesise evidence on the patterns, determinants, and interventions associated with rational antidiabetic and antihypertensive medication use among adults with coexisting diabetes and hypertension, and to propose a conceptual framework.
Methods: Following PRISMA 2020, PubMed, ScienceDirect, and Google Scholar (first 300 records) were searched for English-language studies published from January 2015 to July 2026. Quality was assessed using the Kmet criteria, and findings were synthesised narratively.
Results: Thirteen studies were included (five intervention, six cross-sectional, two qualitative), with quality scores of 85.7–100%; 11 were from low- and middle-income countries, and six enrolled mixed populations without separate results for the comorbid subgroup. All five interventions were pharmacist-led, and all four with extractable results improved at least one adherence measure, whereas effects on blood pressure and glycaemic control were inconsistent. Medication burden, limited knowledge, beliefs about medicines, affordability, and inadequate follow-up were recurring barriers. No study evaluated deprescribing or provider-focused interventions. Findings were organised into a six-component conceptual framework (ADHERE), in which deprescribing and provider support remain untested hypotheses.
Conclusion: Pharmacist-led education and follow-up were associated with improved adherence, but evidence on clinical outcomes and prescribing quality is limited. ADHERE is unvalidated and requires consensus and feasibility testing before implementation.
Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework
International Journal of Evidence-Based Medicine, 1(4), 2026, jebm018, https://doi.org/10.63946/jebm/19983
Publication date: Nov 20, 2026
ABSTRACT
KEYWORDS
Rational Medication Use Diabetes Mellitus Hypertension Medication Adherence Polypharmacy Medication Optimisation Health Literacy Conceptual Framework
CITATION (Vancouver)
Tata L, Ameh AD, Musa AS, Adewale AO. Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework. International Journal of Evidence-Based Medicine. 2026;1(4):jebm018. https://doi.org/10.63946/jebm/19983
APA
Tata, L., Ameh, A. D., Musa, A. S., & Adewale, A. O. (2026). Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework. International Journal of Evidence-Based Medicine, 1(4), jebm018. https://doi.org/10.63946/jebm/19983
Harvard
Tata, L., Ameh, A. D., Musa, A. S., and Adewale, A. O. (2026). Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework. International Journal of Evidence-Based Medicine, 1(4), jebm018. https://doi.org/10.63946/jebm/19983
AMA
Tata L, Ameh AD, Musa AS, Adewale AO. Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework. International Journal of Evidence-Based Medicine. 2026;1(4), jebm018. https://doi.org/10.63946/jebm/19983
Chicago
Tata, Leo, Anyebe Daniel Ameh, Adesina Saheed Musa, and Adetayo Olufunlayo Adewale. "Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework". International Journal of Evidence-Based Medicine 2026 1 no. 4 (2026): jebm018. https://doi.org/10.63946/jebm/19983
MLA
Tata, Leo et al. "Rational Use of Antidiabetics and Antihypertensives Among Adults with Coexisting Diabetes and Hypertension: A Systematic Review and a Proposed ADHERE-Prescription Medication Optimisation Framework". International Journal of Evidence-Based Medicine, vol. 1, no. 4, 2026, jebm018. https://doi.org/10.63946/jebm/19983
REFERENCES
- International Diabetes Federation. IDF Diabetes Atlas 2025 [Internet]. 2025 [cited 2026 Jul 12]. Available from: https://diabetesatlas.org/resources/idf-diabetes-atlas-2025/
- World Health Organization. Global report on hypertension: the race against a silent killer [Internet]. 2023 [cited 2026 Sep 12]. Available from: https://www.who.int/publications/i/item/9789240081062
- Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol. 2018 Jun 8;17(1):83. doi:10.1186/s12933-018-0728-6
- Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018 May 1;34(5):575–84. doi:10.1016/j.cjca.2017.12.005
- Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10;17(1):230. doi:10.1186/s12877-017-0621-2
- Varghese D, Patel P. Polypharmacy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 [cited 2026 Jul 12]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532953/
- World Health Organization. The rational use of drugs: report of the Conference of Experts, Nairobi, 25–29 November 1985. Geneva: World Health Organization; 1987.
- World Health Organization. Medication safety in polypharmacy: technical report [Internet]. 2019 [cited 2026 Jul 12]. Available from: https://www.who.int/publications/i/item/WHO-UHC-SDS-2019.11
- Sabaté E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
- National Institute for Health and Care Excellence. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NICE guideline NG5. London: NICE; 2015.
- Wang J, Tan F, Wang Z, Yu Y, Yang J, Wang Y, et al. Understanding gaps in the hypertension and diabetes care cascade: systematic scoping review. JMIR Public Health Surveill. 2024 Feb 16;10:e51802. doi:10.2196/51802
- Zaman Huri H, Fun Wee H. Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord. 2013 Jan 7;13:2. doi:10.1186/1472-6823-13-2
- American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2025. Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S27–49. doi:10.2337/dc25-S002
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018 Sep 1;39(33):3021–104. doi:10.1093/eurheartj/ehy339
- Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016 Jul 22;10:1299–307. doi:10.2147/PPA.S106821
- Khunti S, Khunti K, Seidu S. Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia. Ther Adv Endocrinol Metab. 2019 May 3;10:2042018819844694. doi:10.1177/2042018819844694
- Maniki PT, Chaar BB, Aslani P. Impact of interventions on medication adherence in patients with coexisting diabetes and hypertension. Health Expect. 2024;27(5):e70010. doi:10.1111/hex.70010
- Siddaway AP, Wood AM, Hedges LV. How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annu Rev Psychol. 2019;70:747–70. doi:10.1146/annurev-psych-010418-102803
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. doi:10.1136/bmj.n71
- Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. doi:10.1136/bmj.l6890
- Adisa R, Olajide OO, Fakeye TO. Social support, treatment adherence and outcome among hypertensive and type 2 diabetes patients in ambulatory care settings in southwestern Nigeria. Ghana Med J. 2017 Jun;51(2):64–77.
- Atinga RA, Yarney L, Gavu NM. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: a qualitative investigation. PLoS One. 2018 Mar 28;13(3):e0193995. doi:10.1371/journal.pone.0193995
- Parra DI, Guevara SLR, Rojas LZ. Influential factors in adherence to the therapeutic regime in hypertension and diabetes. Invest Educ Enferm. 2019 Oct 23;37(3). doi:10.17533/udea.iee.v37n3e02
- Sharma N, Mariam W, Basu S, Shrivastava R, Rao S, Sharma P, et al. Determinants of treatment adherence and health outcomes in patients with type 2 diabetes and hypertension in a low-income urban agglomerate in Delhi, India: a qualitative study. Cureus. 2023 Feb 9;15. doi:10.7759/cureus.34826
- Khayyat SM, Mohamed MMA, Khayyat SMS, Hyat Alhazmi RS, Korani MF, Allugmani EB, et al. Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey. Qual Life Res. 2019 Apr 1;28(4):1053–61. doi:10.1007/s11136-018-2060-8
- Shimels T, Kassu RA, Bogale G, Bekele M, Getnet M, Getachew A, et al. Magnitude and associated factors of poor medication adherence among diabetic and hypertensive patients visiting public health facilities in Ethiopia during the COVID-19 pandemic. PLoS One. 2021 Apr 6;16(4):e0249222. doi:10.1371/journal.pone.0249222
- National Library of Medicine. Medical Subject Headings – Home Page [Internet]. U.S. National Library of Medicine; [cited 2026 Jul 12]. Available from: https://www.nlm.nih.gov/mesh/meshhome.html
- Bramer WM, de Jonge GB, Rethlefsen ML, Mast F, Kleijnen J. A systematic approach to searching: an efficient and complete method to develop literature searches. J Med Libr Assoc. 2018 Oct 4;106(4):531–41. doi:10.5195/jmla.2018.283
- Haddaway NR, Collins AM, Coughlin D, Kirk S. The role of Google Scholar in evidence reviews and its applicability to grey literature searching. PLoS One. 2015;10(9):e0138237. doi:10.1371/journal.pone.0138237
- Kmet LM, Cook LS, Lee RC. Standard quality assessment criteria for evaluating primary research papers from a variety of fields [Internet]. 2004 Feb 1. doi:10.7939/R37M04F16
- Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. Lancaster: Lancaster University; 2006.
- Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. doi:10.1186/1471-2288-8-45
- Contreras-Vergara A, Sifuentes-Franco S, Haack S, Graciano-Machuca O, Rodriguez-Carrizalez AD, López-Contreras AK, et al. Impact of pharmaceutical education on medication adherence and its clinical efficacy in patients with type 2 diabetes and systemic arterial hypertension. Patient Prefer Adherence. 2022 Aug 5;16:1999–2007. doi:10.2147/PPA.S370323
- Alfian SD, van Boven JFM, Abdulah R, Sukandar H, Denig P, Hak E. Effectiveness of a targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: a cluster randomised controlled trial. Br J Clin Pharmacol. 2021;87(4):2032–42. doi:10.1111/bcp.14610
- Kwakye AO, O BK, M OANA, E OD. Clinical pharmacists education and counselling in patients with co-morbid hypertension and diabetes in a municipal hospital in Ghana. Afr J Pharm Pharmacol. 2021 Oct 31;15(10):183–90. doi:10.5897/AJPP2021.5267
- Malik M, Hussain A, Aslam U, Hashmi A, Vaismoradi M, Hayat K, et al. Effectiveness of community pharmacy diabetes and hypertension care program: an unexplored opportunity for community pharmacists in Pakistan. Front Pharmacol. 2022 May 17;13. doi:10.3389/fphar.2022.710617
- Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, James Essien E, et al. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a Medicare Advantage plan. J Manag Care Spec Pharm. 2016 Jan;22(1):63–73. doi:10.18553/jmcp.2016.22.1.63
- Baah-Nyarkoh E, Alhassan Y, Dwomoh AK, Kretchy IA. Medication-related burden and adherence in patients with co-morbid type 2 diabetes mellitus and hypertension. Heliyon. 2023 Apr 1;9(4). doi:10.1016/j.heliyon.2023.e15448
- Mazzuchello FR, Tuon L, Simões PW, Mazon J, Dagostin VS, Tomasi CD, et al. Knowledge, attitudes and adherence to treatment in individuals with hypertension and diabetes mellitus. Mundo Saúde. 2016 Oct 1;40(4):418–32. doi:10.15343/0104-7809.20164004418432
- Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2–4.
- Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi:10.1186/1748-5908-6-42
- Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018 Dec 18;320(23):2461–73. doi:10.1001/jama.2018.19271
- Reeves L, Robinson K, McClelland T, Adedoyin CA, Broeseker A, Adunlin G. Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials. J Pharm Pract. 2021 Jun;34(3):480–92. doi:10.1177/0897190020903573
- Bingham JM, Black M, Anderson EJ, Li Y, Toselli N, Fox S, et al. Impact of telehealth interventions on medication adherence for patients with type 2 diabetes, hypertension, and/or dyslipidemia: a systematic review. Ann Pharmacother. 2021 May;55(5):637–49. doi:10.1177/1060028020950726
- Yap HJ, Lim JJJ, Tan SYD, Ang CS. Effectiveness of digital health interventions on adherence and control of hypertension: a systematic review and meta-analysis. J Hypertens. 2024 Sep 1;42(9):1490–504. doi:10.1097/HJH.0000000000003793
- Huiskes VJB, Burger DM, van den Ende CHM, van den Bemt BJF. Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials. BMC Fam Pract. 2017 Jan 17;18:5. doi:10.1186/s12875-016-0577-x
- Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. doi:10.1186/1748-5908-4-50
- Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374:n2061. doi:10.1136/bmj.n2061
- Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on conducting and reporting Delphi studies (CREDES) in palliative care: recommendations based on a methodological systematic review. Palliat Med. 2017;31(8):684–706. doi:10.1177/0269216317690685
LICENSE
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.